One Pager as on November 30,2025
![]() | Prudent portfolio of investments across companies and sectors. |
![]() | Actively managed by professional fund managers for potential long term capital appreciation. |
![]() | Opportunity to participate in successful businesses through equity market. |
| Sector | MMMCF* | Nifty 500 Multicap 50:25:25 TRI |
| Financial Services | 30.93% | 29.79% |
| Healthcare | 14.61% | 7.94% |
| Capital Goods | 10.90% | 7.99% |
| Information Technology | 6.81% | 7.31% |
| Automobile And Auto Components | 6.60% | 7.07% |
*Mahindra Manulife Multi Cap Fund
Data as on November 30,2025
| Security | % to Net Assets |
| ICICI Bank Limited | 3.18% |
| Glenmark Pharmaceuticals Limited | 3.14% |
| Divi's Laboratories Limited | 3.01% |
| Indus Towers Limited | 2.94% |
| State Bank of India | 2.49% |
| UltraTech Cement Limited | 2.37% |
| Polycab India Limited | 2.35% |
| Angel One Limited | 2.32% |
| The Federal Bank Limited | 2.27% |
| JSW Steel Limited | 2.27% |
| Total | 26.34% |
| Fresh Additions | Complete Exits |
| Security | Security |
| Shriram Finance Ltd | PI Industries Ltd |
| Aurobindo Pharma Ltd | Canara Bank |
| Multi Commodity Exchange of India Ltd | Bharat Electronics Ltd |
| Jamna Auto Industries Ltd | Amara Raja Energy & Mobility Ltd |
| Sagility Ltd | HDFC Bank Ltd |
| CG Power and Industrial Solutions Ltd | ITC Hotels Ltd |
| Astral Ltd | Bharat Dynamics Ltd |
| Ashok Leyland Ltd | Safari Industries (India) Ltd |
| Larsen & Toubro Ltd | Vishal Mega Mart Ltd |
| Manappuram Finance Ltd | Mankind Pharma Ltd |
| Bank of Baroda | eClerx Services Ltd |
| - | Syngene International Ltd |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s). Data as on November 30,2025
| Turnover Ratio (Last 1 year) | 0.99 |
| Standard Deviation | 15.00% |
| Beta | 1.00 |
| Sharpe Ratio# | 0.89 |
| Jenson's Alpha | 0.0917 |
#Risk-free rate assumed to be 5.59% (MIBOR as on 28-11-25) - Source: www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns
for last 3 years. Data as on November 28, 2025
$Note: Pursuant to notice cum addendum no. 46/2025, Mr. Manish Lodha, Fund Manager – Equity and a Key Personnel of MMIMPL has resigned from the services of MMIMPL effective from December 02, 2025
Date of allotment: May 11, 2017
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Vishal Jajoo is managing this fund since November 3, 2025, Ms. Fatema Pacha is managing this scheme since October 16, 2020 and Mr. Manish Lodha is managing this fund since December 21, 2020. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period.
$Note: Pursuant to notice cum addendum no. 46/2025, Mr. Manish Lodha, Fund Manager – Equity and a Key Personnel of MMIMPL has resigned from the services of MMIMPL effective from December 02, 2025
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 11-May-17.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Vishal Jajoo manages 1 scheme, Ms. Fatema Pacha
manages 8 schemes and Mr. Manish Lodha manages 10 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Note: As November 29 & 30, 2025 was a non-business days, the schemes returns disclosed are as on November 28, 2025, except for Mahindra Manulife Liquid Fund and Mahindra Manulife Overnight Fund which is as of November 30, 2025.
¢Note: Pursuant to notice cum addendum no. 45/2025, Fund Manager of the scheme has been changed with effect from December 02, 2025.
$Note: Pursuant to notice cum addendum no. 46/2025, Mr. Manish Lodha, Fund Manager – Equity and a Key Personnel of MMIMPL has resigned from the services of MMIMPL effective from December 02, 2025
Note: The performance data of Mahindra Manulife Value Fund has not been provided as the scheme has not completed 1 year since inception. The said Scheme is managed by Mr. Krishna Sanghavi & Mr. Vishal Jajoo. The performance data of Mahindra Manulife Banking & Financial Services Fund has not been provided as the scheme has not completed 1 year since inception. The said Scheme is managed by Mr. Vishal Jajoo & Mr. Chetan Sanjay Gindodia.
This product is suitable for investors who are seeking*:
• Medium to Long term capital
appreciation.
• Investment predominantly in
equity and equity related securities
including derivatives.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.